Evidence map›Paper›PMID 26110254›Full record

Trial reportJAMA ophthalmology2015

Association of pretreatment with antifungal medication and fungal resistance in the mycotic ulcer treatment trial I.

N Venkatesh Prajna, Lalitha Prajna, Kieran S O'Brien, Catherine Q Sun, Nisha Acharya, Thomas M Lietman, Jennifer Rose-Nussbaumer, Mycotic Ulcer Treatment Trial Group

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in JAMA ophthalmology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

N Venkatesh PrajnaAravind Eye Care System, Madurai, India.
Lalitha PrajnaAravind Eye Care System, Madurai, India.
Kieran S O'BrienFrancis I. Proctor Foundation, University of California, San Francisco.
Catherine Q SunFrancis I. Proctor Foundation, University of California, San Francisco.
Nisha AcharyaFrancis I. Proctor Foundation, University of California, San Francisco3Department of Epidemiology and Biostatistics, University of California, San Francisco4Department of Ophthalmology, University of California, San Francisco.
Thomas M LietmanFrancis I. Proctor Foundation, University of California, San Francisco3Department of Epidemiology and Biostatistics, University of California, San Francisco4Department of Ophthalmology, University of California, San Francisco.
Jennifer Rose-NussbaumerFrancis I. Proctor Foundation, University of California, San Francisco4Department of Ophthalmology, University of California, San Francisco5Department of Optometry, University of California, Berkeley.
Mycotic Ulcer Treatment Trial Group

Funding

Myocotic Ulcer Treatment TrialU10EY018573 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIETMAN, THOMAS M · 2009 to 2014
$3.7M
Predictions of Response to Treatment in Fungal KeratitisK23EY025025 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ROSE-NUSSBAUMER, JENNIFER · 2015 to 2019
$1.2M
NEI NIH HHS K23 EY025025NEI NIH HHS L30 EY025876NEI NIH HHS U10 EY018573NEI NIH HHS U10-EY018573-01A1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, FungalAdministration, OralAdministration, TopicalAdultAntifungal AgentsAspergillosisAspergillus fumigatusCorneal UlcerDouble-Blind MethodEye Infections, FungalFemaleFusariosisFusariumHumansMaleMicrobial Sensitivity TestsAntifungal AgentsNatamycinVoriconazole

Identifiers

PMID26110254
PMCPMC4962690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.